首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1609789

2024-2032 年日本再生醫學市場報告（按類型、應用、最終用戶和地區）

Japan Regenerative Medicine Market Report by Type, Application, End User, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2023年日本再生醫學市場IMARC Group達76億美元。該市場受到一系列因素的推動，包括對移植排斥的擔憂加劇、對再生骨科治療的更大需求、對牙齒再生的日益關注以及傷口癒合藥物的日益使用。

再生醫學是生物醫學科學中的一個有利領域，專注於修復受損的組織和器官。它涉及使用實驗室培養的幹細胞，將其安全地移植到體內，以促進骨骼、軟骨、血管和重要器官等各種身體組成的再生。這種綜合方法包括各種細胞和非細胞再生療法，並結合了免疫調節和組織工程等技術。除了在組織修復中的作用外，再生醫學在解決阿茲海默症、帕金森氏症、心血管疾病 (CVD)、骨質疏鬆症和脊髓損傷等持續性疾病方面也顯示出巨大的前景。隨著研究的進展，它對革命性的治療方法提出了樂觀的前景，這些治療方法有可能顯著提高患者的生活品質和整體醫療保健結果。

日本再生醫學市場趨勢：

日本再生醫學市場正在經歷大幅成長，這主要是由於老年人口的不斷擴大。這種人口結構的變化與糖尿病、心臟病和骨關節炎等慢性疾病發病率的升高有關，從而極大地促進了市場的擴張。此外，對幹細胞療法和基因工程研究的日益關注正在促進再生醫學領域的創新。為了組織再生和修復而擴大利用幹細胞和其他細胞療法進一步刺激了市場。值得注意的是，市場的積極發展軌跡是透過為再生醫學研究和開發的進步分配資金和監管支持而得以維持的。生物技術的不斷進步正在促進更精確、更有效的再生療法的開發，從而促進市場的成長。此外，患者對再生治療方案可用性的認知不斷提高，這也成為市場擴張的額外催化劑。癌症發病率的增加以及對更有效、更適合患者的治療方法的追求正在推動癌症治療中對再生醫學的需求，在市場的成長中發揮著重要作用。

日本再生醫學市場細分：

類型見解：

幹細胞治療
生物材料
組織工程
其他

應用見解：

骨移植替代品
骨關節疾病
皮膚科
心血管
中樞神經系統
其他

最終使用者見解：

醫院
專科診所
其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本再生醫學市場迄今表現如何，未來幾年又將如何表現？
COVID-19 對日本再生醫學市場有何影響？
日本再生醫學市場按類型分類是怎樣的？
日本再生醫學市場的應用基礎如何細分？
日本再生醫學市場的最終用戶細分如何？
日本再生醫學市場價值鏈的各個階段是什麼？
日本再生醫學的關鍵促進因素和挑戰是什麼？
日本再生醫學市場的結構如何？
日本再生醫學市場的競爭程度如何？

本報告回答的關鍵問題：

日本再生醫學市場迄今表現如何，未來幾年又將如何表現？
COVID-19 對日本再生醫學市場有何影響？
日本再生醫學市場按類型分類是怎樣的？
日本再生醫學市場的應用基礎如何細分？
日本再生醫學市場的最終用戶細分如何？
日本再生醫學市場價值鏈的各個階段是什麼？
日本再生醫學的關鍵促進因素和挑戰是什麼？
日本再生醫學市場的結構如何？
日本再生醫學市場的競爭程度如何？

幹細胞治療
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
生物材料
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
組織工程
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 7 章：日本再生醫學市場 - 細分：依應用分類

骨移植替代品
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
骨關節疾病
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
皮膚科
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
心血管
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
中樞神經系統
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 8 章：日本再生醫學市場 - 細分：依最終用戶分類

醫院
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
專科診所
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 9 章：日本再生醫學市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 10 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本再生醫學市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 12 章：附錄

簡介目錄

Product Code: SR112024A19898

Japan regenerative medicine market size reached US$ 7.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.70% during 2024-2032. The market is being driven by a range of factors, including heightened worries about transplant rejection, a greater need for regenerative orthopedic treatments, an increasing focus on dental regeneration, and the growing utilization of medicine for wound healing.

Regenerative medicine is an auspicious field within biomedical science that focuses on repairing damaged tissues and organs. It involves the use of laboratory-cultivated stem cells, which are safely transplanted into the body to encourage the regeneration of various bodily components such as bones, cartilage, blood vessels, and essential organs. This comprehensive approach includes a variety of regenerative therapies, both cellular and acellular, incorporating techniques like immunomodulation and tissue engineering. Apart from its role in tissue repair, regenerative medicine shows great promise in addressing persistent conditions such as Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research progresses, it presents an optimistic outlook for revolutionary treatments that have the potential to significantly enhance patients' quality of life and overall healthcare outcomes.

Japan Regenerative Medicine Market Trends:

The Japan regenerative medicine market is experiencing substantial growth primarily due to the expanding elderly population. This demographic shift correlates with a heightened incidence of chronic ailments like diabetes, heart disease, and osteoarthritis, thus significantly contributing to the market's expansion. Moreover, the increasing focus on stem cell therapies and genetic engineering research is fostering innovation within the realm of regenerative medicine. The market is further stimulated by the growing utilization of stem cells and other cell-based therapies for the purpose of tissue regeneration and repair. Notably, the positive trajectory of the market is sustained by the allocation of funding and regulatory support for the advancement of regenerative medicine research and development. The continual advancements in biotechnology are facilitating the development of more precise and efficacious regenerative therapies, thereby bolstering the market's growth. Additionally, the rising awareness among patients regarding the availability of regenerative treatment options is serving as an additional catalyst for market expansion. The increasing occurrence of cancer and the quest for treatments that are both more efficient and accommodating for patients are driving the need for regenerative medicine in cancer treatment, playing a substantial role in the growth of the market.

Japan Regenerative Medicine Market Segmentation:

Type Insights:

Stem Cell Therapy
Biomaterial
Tissue Engineering
Others

Application Insights:

Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others

End User Insights:

Hospitals
Specialty Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan regenerative medicine market?
What is the breakup of the Japan regenerative medicine market on the basis of type?
What is the breakup of the Japan regenerative medicine market on the basis of application?
What is the breakup of the Japan regenerative medicine market on the basis of end user?
What are the various stages in the value chain of the Japan regenerative medicine market?
What are the key driving factors and challenges in the Japan regenerative medicine?
What is the structure of the Japan regenerative medicine market and who are the key players?
What is the degree of competition in the Japan regenerative medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Regenerative Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Regenerative Medicine Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Regenerative Medicine Market - Breakup by Type

6.1 Stem Cell Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Biomaterial
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Tissue Engineering
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
6.4 Others
- 6.4.1 Historical and Current Market Trends (2018-2023)
- 6.4.2 Market Forecast (2024-2032)

7 Japan Regenerative Medicine Market - Breakup by Application

7.1 Bone Graft Substitutes
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Osteoarticular Diseases
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Dermatology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
7.4 Cardiovascular
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2018-2023)
- 7.4.3 Market Forecast (2024-2032)
7.5 Central Nervous System
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2018-2023)
- 7.5.3 Market Forecast (2024-2032)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2018-2023)
- 7.6.2 Market Forecast (2024-2032)

8 Japan Regenerative Medicine Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Specialty Clinics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2018-2023)
- 8.3.2 Market Forecast (2024-2032)

9 Japan Regenerative Medicine Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Regenerative Medicine Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis